GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
8.37436 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, F3, FABP3, FABP4, FLT3, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, KDR, MET, PPARA, SRC, XDH |
7.82924 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
7.81247 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.42973 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.42973 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, XDH |
7.41022 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, XDH |
7.40524 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
7.40524 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HSD17B2, HTR5A, IGF1R, KDR, PPARA, RORC, SRC, TYR |
6.8012 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, XDH |
6.76959 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
6.74576 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, PPARA, RORC, SRC, TYR |
6.57417 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, HTR1A, TYR |
6.4165 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FUT7, HTR2B, PIM1, PPARA, TYR, XDH |
6.39996 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD2, FABP3, FABP4, FUT7, HSD17B2, MET, PPARA |
6.34767 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
6.34767 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM2, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
6.20271 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, TYR |
6.13866 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
6.06141 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD17B2, HTR5A, IGF1R, PPARA, RORC, SRC, TYR |
6.01202 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, BCL2, CDC25B, CYP1B1, DRD2, DRD3, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, PIM1, SRC, XDH |
6.01202 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.87265 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
5.87265 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, F3, FABP4, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MET, PIM1, PPARA, RORC, SRC, TYR |
5.86564 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, FLT3, HTR5A, RORC, SRC, TYR |
5.78834 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KDR, SRC |
5.72149 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, MET, SRC |
5.66644 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, SRC |
5.59077 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
5.57676 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CDC25B, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP4, FLT3, FUT7, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, MET, PIM1, PPARA, RORC, SIGMAR1, SRC, TYR |
5.39329 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.36553 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CYP1B1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PTPN1, SRC, XDH |
5.35669 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HSD17B2 |
5.27665 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
5.23917 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
5.1668 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, SRC |
5.05723 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, XDH |
5.05285 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, HTR2A, HTR2B, PPARA, RORC, SRC |
4.99557 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
4.99557 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, HTR5A, RORC, SRC, TYR |
4.99557 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.97305 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.97305 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.95506 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CHRM2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, F3, FABP3, FABP4, FLT3, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, PPARA, PTPN1, RORC, SRC, TYR |
4.94806 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PTPN1, SRC, XDH |
4.84805 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.82615 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.81401 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
4.78917 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PTPN1, SRC, XDH |
4.77057 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.75116 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.75116 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, HSD17B2, HTR1A, HTR2A |
4.75057 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.6955 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.6955 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CYP1B1, F3, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SIGMAR1, SRC, XDH |
4.66368 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, AXL, BCL2, CA2, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, HSD17B2, HTR5A, KDR, PIM1, PPARA, RORC, SIGMAR1, SRC, TYR |
4.66368 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
4.65445 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, FABP3, FABP4, HTR2A, HTR2B, MET |
4.63224 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3 |
4.62836 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM2, DRD1, DRD2, HTR2A, HTR2B |
4.60917 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
4.59391 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, FABP3, PPARA |
4.58044 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD2, FABP3, FABP4, FUT7, MET, PPARA |
4.54319 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
4.42215 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CYP1B1, F3, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PTPN1, SIGMAR1, SRC, XDH |
4.4096 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
4.36444 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HTR2A, HTR2B, PPARA, SRC, TYR |
4.35434 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PPARA, PTPN1, SRC, XDH |
4.34212 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PPARA, PTPN1, SRC, XDH |
4.29402 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PTPN1, SRC |
4.29157 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AXL, BCL2, CA1, CA2, CHRM2, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SRC |
4.22299 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
4.16242 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, PIM1 |
4.16242 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
4.1404 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, IGF1R, KDR, MET, SRC |
4.13685 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B2 |
4.1242 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, DRD1, DRD2, DRD3, HTR1A |
4.03837 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
4.02611 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B2 |
4.00035 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, RORC |
4.00035 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, SRC |
3.9614 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.95871 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
3.93388 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
3.93388 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.93368 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.90692 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, DRD2, DRD3, HTR7, PPARA, RORC, SRC |
3.9 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, DRD2, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
3.89893 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2 |
3.89014 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SRC |
3.87625 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
3.85493 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PPARA, PTPN1, SRC, XDH |
3.8236 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CYP1B1, F3, FLT3, HTR2B, IGF1R, KDR, PIM1, PTPN1, SIGMAR1, SRC, XDH |
3.8236 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
3.8236 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CYP1A2, FABP3, FLT3, HTR5A, PPARA, SRC |
3.82153 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.81557 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.81557 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B |
3.76713 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, BCL2, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MET, PTPN1, SRC |
3.75718 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, BCL2, CA2, CYP1A2, DRD1, FABP3, FLT3, HTR5A, IGF1R, PPARA, SRC |
3.74737 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, SRC |
3.7464 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, DRD3, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MET, PTPN1, SRC, XDH |
3.72 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.71151 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.71151 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F3, MET, SRC, XDH |
3.71151 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, FABP3, PPARA |
3.70288 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.67383 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AXL, BCL2, CA2, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
3.63671 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
3.61456 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PTPN1, SRC, XDH |
3.61456 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, HTR2B, IGF1R, KDR, MET, PIM1, PTPN1, SRC |
3.53981 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.53981 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, SRC |
3.53072 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
3.53072 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, PTPN1, SRC, XDH |
3.52764 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
3.4404 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.43979 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, SRC |
3.43031 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
3.42942 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HSD17B2, TYR, XDH |
3.42683 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.42683 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TYR, XDH |
3.35699 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TYR, XDH |
3.32681 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
3.31836 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
3.31574 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, AURKB, BCL2, CDC25B, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MET, PIM1, PPARA, PTPN1, SRC, XDH |
3.28384 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
3.281 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC |
3.24925 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
3.24884 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA |
3.23031 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.2227 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
3.2227 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
3.22209 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
3.22209 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
3.22184 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2 |
3.19128 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.17155 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
3.16857 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, BCL2, CA12, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
3.16336 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
3.15677 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
3.14264 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
3.14264 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PTPN1, SRC, XDH |
3.1415 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
3.123 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, FLT3, HTR1A, MET, PIM1, SRC, TYR |
3.1067 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
3.10321 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, HTR2A, HTR2B, KDR, PTPN1, SRC |
3.08381 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, IGF1R, MET, PTPN1, SRC, XDH |
3.08106 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, PPARA |
3.07942 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CYP1B1, CYP2D6, DRD2, DRD3, FABP4, IGF1R, MET, PIM1, PPARA, PTPN1, SRC |
3.07205 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
3.06695 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
3.06484 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.06195 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
3.00169 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.99496 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.99496 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.99475 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, CYP1B1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR7, SRC, TYR |
2.99167 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.97266 |
[BP] GO:0007268 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.9408 |
[BP] GO:0098916 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.9408 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, HTR2B, IGF1R, KDR, PIM1, PTPN1, SRC |
2.92494 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PTPN1, SRC, XDH |
2.92494 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, RORC, SRC |
2.91244 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA |
2.91072 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PTPN1, RORC, SRC, XDH |
2.90228 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.90228 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, SRC |
2.90128 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC, XDH |
2.90128 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, DRD2, HTR2A, HTR2B, KDR, SRC |
2.8964 |
[BP] GO:0099536 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.8964 |
[BP] GO:0099537 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.8964 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.88425 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.88425 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AXL, BCL2, CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.88403 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.87369 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, PPARA, PTPN1, SRC |
2.86705 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.82921 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.80756 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.80756 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.7777 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.7777 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.75479 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.74721 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B2 |
2.72899 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.72899 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.72899 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.72899 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.72899 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, RORC, SRC |
2.72061 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, BCL2, DRD1, DRD2, DRD3, HTR2A, IGF1R, MET, PTPN1, SRC, XDH |
2.72061 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, BCL2, DRD1, DRD2, DRD3, HTR2A, IGF1R, MET, PTPN1, SRC, XDH |
2.70814 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.7011 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.7011 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.66446 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, PPARA, SRC, TYR |
2.64917 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PTPN1, RORC, SRC, XDH |
2.63114 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR1A, HTR2A |
2.62459 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3 |
2.6134 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, PPARA, RORC |
2.59839 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.59839 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.59839 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.5975 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.5975 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, F3, HTR2A, HTR2B, KDR, MET, PIM1, SRC |
2.59001 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.5808 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, F3, FABP4, KDR, MET, PPARA |
2.55969 |
[BP] GO:0030534 |
None
|
DRD1, DRD2, DRD3, HTR2A, PPARA |
2.55208 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.55208 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.55208 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.55208 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.55105 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, PTPN1, SRC, XDH |
2.549 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, HTR2A |
2.549 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.549 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.549 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, XDH |
2.549 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, DRD3, HTR2B, SRC |
2.549 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, DRD1, FLT3, RORC, SRC |
2.54149 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC |
2.54149 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PPARA, PTPN1, SRC, XDH |
2.54001 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.53125 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3 |
2.51208 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.49624 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PTPN1, RORC, SRC, XDH |
2.49183 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.47689 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.47689 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, XDH |
2.46482 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F3, FLT3, FUT7, HTR1A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SRC, TYR, XDH |
2.46365 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, DRD2, DRD3, PPARA |
2.46301 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, BCL2, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.44497 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.43812 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, PPARA, SRC, TYR |
2.43364 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
2.43044 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PPARA, PTPN1, RORC, SRC, XDH |
2.4271 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, SRC, XDH |
2.41058 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.3948 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.3948 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.3948 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A |
2.39429 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, FLT3, HTR2A, HTR2B, PTPN1, SRC |
2.38979 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.3853 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, AURKB, AXL, BCL2, CYP1B1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MET, PTPN1, SRC, XDH |
2.3853 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
2.38221 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, PPARA, SRC |
2.36411 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.36047 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, DRD2, F3, FLT3, HTR2A, HTR2B, PTPN1, SRC, XDH |
2.35629 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HTR2B, SRC |
2.35619 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, PTPN1, SRC |
2.33619 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F3, FABP3, FABP4, FLT3, FUT7, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SRC, TYR, XDH |
2.33619 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, SRC |
2.33224 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, FLT3, HTR2A, HTR2B, PTPN1, SRC |
2.33224 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, BCL2, CYP19A1 |
2.33224 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.33224 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.33224 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2 |
2.33224 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.33224 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.33224 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.33224 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.33224 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.33224 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.33224 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, FLT3, HTR2A, HTR2B, PTPN1, SRC |
2.33224 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, PPARA, SRC |
2.31905 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.30481 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R |
2.30481 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.30481 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.30481 |
[BP] GO:0007610 |
None
|
BCL2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, PPARA |
2.28305 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
2.28176 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.28016 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, HTR6 |
2.27212 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.27212 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A |
2.27212 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, FLT3, HTR2A, HTR2B, PTPN1, SRC |
2.24647 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, HTR2A, HTR2B |
2.23414 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, PPARA |
2.23375 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, HTR2A, PTPN1, SRC |
2.22779 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2 |
2.22779 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A |
2.22176 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.2188 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, SRC |
2.21466 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, BCL2, CYP19A1, DRD1, DRD2, DRD3, IGF1R, MET, PPARA, PTPN1, SRC, XDH |
2.21068 |
[BP] GO:0009416 |
response to light stimulus
|
AURKB, BCL2, DRD1, DRD2, DRD3, TYR |
2.19823 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM2, DRD2, HTR2A |
2.19823 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.19823 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.19823 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.19823 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.19823 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.19823 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, BCL2, DRD1, DRD2, DRD3, HTR2A, HTR2B |
2.17676 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, PPARA, SRC |
2.15619 |
[BP] GO:0043112 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.15057 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, SRC |
2.14989 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, HTR2A, HTR2B |
2.14745 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, AURKB, BCL2, CDC25B, DRD2, F3, FLT3, HTR2A, HTR2B, MET, PTPN1, SRC, XDH |
2.12729 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2 |
2.1225 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3 |
2.11638 |
[BP] GO:0043266 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
2.10674 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, BCL2, CDC25B, DRD2, F3, FLT3, HTR2A, HTR2B, KDR, PTPN1, SRC, XDH |
2.10579 |
[BP] GO:0030098 |
lymphocyte differentiation
|
AXL, BCL2, FLT3, FUT7, RORC |
2.09063 |
[BP] GO:0014075 |
None
|
DRD1, DRD2, DRD3 |
2.08627 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.07814 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2D6 |
2.07814 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2D6 |
2.07814 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B |
2.07814 |
[BP] GO:1904180 |
negative regulation of membrane depolarization
|
BCL2, SRC |
2.07814 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, HTR2A, MET, SRC |
2.0726 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, HTR2A, MET, SRC |
2.0726 |
[BP] GO:0030260 |
entry into host cell
|
AXL, HTR2A, MET, SRC |
2.0726 |
[BP] GO:0044409 |
entry into host
|
AXL, HTR2A, MET, SRC |
2.0726 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1 |
2.05723 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, DRD1, F3, IGF1R, KDR, MET, SRC |
2.05654 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2 |
2.0362 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CA4, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
7.41445 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
6.20271 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F3, FLT3, FUT7, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPN1, SIGMAR1, SRC, TYR |
5.57742 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F3, FLT3, FUT7, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PIM1, PTPN1, SIGMAR1, SRC, TYR |
4.81401 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, AXL, CA2, CA4, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SRC |
4.77969 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA2, CA4, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PIM1, PTPN1, SRC |
3.93205 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CA4, CHRM2, CYP3A4, DRD1, DRD2, DRD3, F3, FLT3, FUT7, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TYR |
3.03895 |
[CC] GO:0005783 |
None
|
ADORA1, BCL2, CA4, CYP19A1, CYP2D6, FLT3, HTR5A, KDR, PTPN1, SIGMAR1, XDH |
2.60909 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CHRM2, DRD1, DRD2, HTR2A, MET, SIGMAR1, SRC |
2.49894 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRA1A, ALPL, AXL, CA12, CA14, CHRM2, CYP3A4, DRD1, DRD2, DRD3, F3, FLT3, FUT7, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TYR |
2.29616 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.19823 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, FLT3, HSD17B2, PTPN1, SIGMAR1 |
2.17859 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, HSD17B2, SIGMAR1 |
2.1225 |
[MF] GO:0008227 |
None
|
ADRA1A, CHRM2, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
9.27833 |
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
8.73602 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
8.73602 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
8.35094 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.35094 |
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.777 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, SIGMAR1, SRC |
7.63566 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
7.63566 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
7.5391 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
7.5391 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
7.46966 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
7.45114 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.42973 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.42973 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.3798 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.3798 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
7.33455 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, RORC, SRC, TYR, XDH |
7.26063 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM2, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC, SIGMAR1 |
7.20768 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
7.10737 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.01202 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
5.69455 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, TYR |
5.64591 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.57742 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, XDH |
5.47592 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
5.38906 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
4.95971 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC |
4.90142 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.90114 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC |
4.74054 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, TYR |
4.45078 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HSD17B2, TYR, XDH |
4.19358 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.95871 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, F3, FLT3, FUT7, HSD17B2, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TYR, XDH |
3.89893 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.67383 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2D6, CYP3A4 |
3.56853 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.53981 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.31574 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
3.2227 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
3.06195 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
3.02636 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.74721 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.72899 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC, XDH |
2.54149 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.49624 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.49624 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.33224 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.30481 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.19823 |
[MF] GO:0005021 |
vascular endothelial growth factor-activated receptor activity
|
FLT3, KDR |
2.07814 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA3 |
2.07814 |